Understanding treatment preferences for metastatic prostate cancer in Hong Kong
A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment
This study is trying to understand what treatments for metastatic prostate cancer patients and doctors in Hong Kong prefer and why.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 306 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Trial ID | NCT05761093 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the preferences of both patients and physicians regarding the risks and benefits associated with treatments for metastatic prostate cancer. By utilizing a discrete choice experiment, the study will gather insights from participants at various stages of the disease to understand their decision-making processes. The findings will help to identify key factors that influence treatment choices in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who have been diagnosed with metastatic prostate cancer within the last five years.
Not a fit: Patients who are unable to complete the survey due to physical or psychological reasons will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more tailored treatment options that align with patient and physician preferences, improving overall satisfaction and outcomes.
How similar studies have performed: While discrete choice experiments have been used in other contexts, this specific approach to understanding treatment preferences in metastatic prostate cancer is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged 18 years or older, * diagnosis of metastatic prostate cancer within 5 years, * able to read and write, * accepting and signing the informed consent Exclusion Criteria: * if patients are unable to complete the survey by themselves due to physical or psychological reasons, * deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons, * deemed ineligible by treating physicians
Where this trial is running
Shatin
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Chi Fai NG, MD — Chinese University of Hong Kong
- Study coordinator: Chi Fai NG, MD
- Email: ngcf@surgery.cuhk.edu.hk
- Phone: 35052625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.